Clinical Trial Update: Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating whether adding asciminib to imatinib improves achievement of treatment-free remission in chronic-phase chronic myeloid leukemia, comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• SCEMBLIX (ASCIMINIB)

Snippet

Sponsor: Sarit Assouline | Conditions: Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive | Phase 3 | Status: ACTIVE_NOT_RECRUITING